Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Glycaemic Control of Levemir® or Insulatard® in Patients With Type 2 Diabetes

NCT00715351 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00715351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00715351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Glycaemic Control of Levemir® or Insulatard® in Patients With Type 2 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
May 31, 2007
Completion date
July 31, 2008
Enrollment
342 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2